Navigation Links
SMaRT Therapeutics Announces Appointment of Dr. John H. Abeles to the Advisory Board
Date:4/30/2013

ers in the small-drug RNA space.  I am pleased to be able to actively participate with SMaRT at this pivotal juncture in RNA-based therapy history."

Dr. Abeles has served as a founder, officer and director for a variety of biotech and pharmaceutical companies, including Althera Medical, Allium, CytoCore, CombiMatrix, HDH Medical, DUSA Pharmaceuticals, Encore Medical, Procyte, Imre Corp., Epitope, Insonus Medical, Neurotrope BioSciences, Serpin Pharma and OncoLyze Therapeutics. Many of Dr. Abeles' companies became publicly traded and/or were acquired by such pharmaceutical companies as Sonova Holdings AG, Merck and Sun Pharmaceuticals. Dr. Abeles currently serves on the Advisory Board of the College of Chemistry at the University of California, Berkeley, and is a Fellow of the Royal Society of Medicine in London. He received his medical degree as well as a degree in pharmacology from the University of Birmingham, England.

"We are honored that Dr. Abeles has joined our Advisory Board," stated Joseph Scime , President and Chief Executive Officer of SMaRT Therapeutics.  "With such a diverse background and successful track record, Dr. Abeles' experience in guiding life science companies through different stages of growth will be a great asset as we advance our mission to develop small-molecule drugs that target RNA. His deep industry relationships and expertise in drug development and professional collaborations will be invaluable to us as we  advance our broad drug pipeline.  We look forward to him joining us for the strategic discussions that will shape the future of SMaRT."

"Our Advisory Board is comprised of leaders in biotechnology, pharmaceuticals and business, and now consists of Ira S. Miller (Chairman), Dr. John H. Abeles , Dr. Matthew D. Disney and Dr. '/>"/>

SOURCE SMaRT Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Smart911 and In Case of Emergency Standard Partner to Enhance Availability of Life Saving Data for Greater Emergency Response
2. ShopSmart Finds Target, Walmart Offer Lower Prices, Bigger Savings on Over-The-Counter Drugs than CVS, Walgreens
3. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
4. mPhase to Pursue Licensing Opportunities for its Smart Drug Delivery System
5. Strategy Analytics: Smartphones and Fast Networks Drive mHealth Growth
6. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
7. Sensortech Announces New, Ligament Balancing TKA Smart Insert
8. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
9. Asthma and Allergy Foundation of America Challenges Patients and Caregivers to Get Smart About Asthma
10. Smart Insurance Company Urges Beneficiaries to Sign Up for Prescription Drug Plans Now
11. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... REDWOOD CITY, Calif., March 19, 2012 Ingenuity Systems, ... life science researchers, today announced that the Weill Cornell ... iReport for use in its sequencing core facility.  Variant ... the output of whole genome and exome sequencing experiments ...
... 19, 2012  Johnson & Johnson (NYSE: JNJ) will provide ... parties on Monday, March 26th at approximately 10:30 ... College of Cardiology (ACC) Annual Scientific Sessions in ... of the EINSTEIN-PE study in treating patients with ...
Cached Medicine Technology:Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility 2
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... of awards in the 2007 Association TRENDS All-Media Contest, ... Society Magazine as well as the category won by ... honored at the Salute to Association Excellence event on ... the official publication of the Society for Biomolecular Sciences. ...
... the past two decades and is now second to back ... than men to suffer from persistent neck pain, in particular ... a computer keyboard. Previous studies have shown conflicting results as ... but there has not been enough high-quality research in this ...
... are looking for,that magic pill that will make us look and ... longer a pill, and nutrition trends of 2008 will,put you on ... all,the hype," said Dr. Clive R. Spray, a biochemist and leader ... can we improve the health of our family and ourselves?, ...
... are so many health,recommendations in the media these days that ... they can make for better,health in the year ahead. ISSA ... strong -- for their top,recommendations for the 10 best things ... ahead. Here are the results of that survey:, ...
... MCKINNEY, Texas, Jan. 4 Torchmark Corporation,(NYSE: ... two of its leading,insurance subsidiaries, United American Life ... from Delaware to Nebraska. Torchmark,plans to redomesticate other ... the premium tax rates in a number of ...
... DaVita Inc. (NYSE:,DVA) announced today that it and ... partnership to provide dialysis and vascular,access services, as ... the greater Phoenix area. The partnership will own ... to provide patients with,access to all available treatment ...
Cached Medicine News:Health News:Strength training of neck muscles relieves chronic pain 2Health News:Nutrition Trends of 2008 2Health News:Nutrition Trends of 2008 3Health News:Nutrition Trends of 2008 4Health News:International Sports Sciences Association's Ten Best Resolutions for Better Health in 2008 2
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Intended for the quantitative determination of alkaline phosphatase activity in serum or plasma. Kinetic reaction. 405 nm wavelength. 830 U/L at 30C linearity. Single vial, dry powder reagent....
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Medicine Products: